The renin-angiotensin system (RAS) remains a cornerstone of cardiovascular and renal physiology, orchestrating vital aspects of blood pressure regulation and fluid-electrolyte balance. At the ...

In terms of geographical markets, North America was the most sizeable region within the renin-angiotensin-system RAS-acting agents market in 2024. Asia-Pacific is forecasted to be the fastest ...

Renin-angiotensin system blockade conferred similar mortality benefits for Black vs. non-Black patients with HF, and despite less benefit for hospitalization for Black patients, absolute benefit ...

An alternative view suggests that virus-induced upregulation of the renin-angiotensin system (RAS) — a hormonal network that regulates blood pressure fluid, and electrolytes — accounts for the ...

Over the years, people with diabetes and high blood pressure were preferably prescribed drugs that act on the renin-angiotensin-aldosterone system (RAS) for the treatment of their hypertension.

“Whether renin-angiotensin system (RAS) inhibition is safe and effective in patients with advanced CKD is unknown,” Edouard L. Fu, BSc, of Leiden University Medical Center, and colleagues wrote.

The renin-angiotensin system (RAS) becomes active at low blood pressure and forms angiotensin II, a hormone that causes blood vessels to constrict, causing blood pressure to rise again.

Effect of renin-angiotensin system (RAS) inhibition on survival in advanced ductal adenocarcinoma (PDAC). Authors: Rachel Winston, Glen J. Weiss, Ashley Baldwin, Samuel Frank, Lucas Tims, Nakia ...

Inhibition of the Renin-Angiotensin System and Vascular Protection Nikos Werner, MD, Michael Böhm, MD Disclosures Cardiovasc Rev Rep. 2003;24 (4) The RAS and the Cardiovascular Continuum ...

It has been suggested that the renin-angiotensin system (RAS) in mammals may participate in the control of blood pressure, regulation of aldosterone secretion, or in renal functions by influencing ...